These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17370621)

  • 41. Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin.
    Dornetshuber R; Heffeter P; Sulyok M; Schumacher R; Chiba P; Kopp S; Koellensperger G; Micksche M; Lemmens-Gruber R; Berger W
    Mol Nutr Food Res; 2009 Jul; 53(7):904-20. PubMed ID: 19517454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human ATP-Binding Cassette transporters ABCB1 and ABCG2 confer resistance to CUDC-101, a multi-acting inhibitor of histone deacetylase, epidermal growth factor receptor and human epidermal growth factor receptor 2.
    Wu CP; Hsiao SH; Su CY; Luo SY; Li YQ; Huang YH; Hsieh CH; Huang CW
    Biochem Pharmacol; 2014 Dec; 92(4):567-76. PubMed ID: 25450670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor for activated C-kinase 1 regulates the cell surface expression and function of ATP binding cassette G2.
    Ikebuchi Y; Ito K; Takada T; Anzai N; Kanai Y; Suzuki H
    Drug Metab Dispos; 2010 Dec; 38(12):2320-8. PubMed ID: 20858845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Advance of research on relationship between ABCG2 and drug resistance in hematologic malignancies - review].
    Qu SQ; Fu ZZ; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):513-8. PubMed ID: 19379601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis.
    Stiburkova B; Miyata H; Závada J; Tomčík M; Pavelka K; Storkanova G; Toyoda Y; Takada T; Suzuki H
    Rheumatology (Oxford); 2016 Jan; 55(1):191-4. PubMed ID: 26428519
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of ABCG2 in transport of the mammalian lignan enterolactone and its secretion into milk in Abcg2 knockout mice.
    Miguel V; Otero JA; García-Villalba R; Tomás-Barberán F; Espín JC; Merino G; Álvarez AI
    Drug Metab Dispos; 2014 May; 42(5):943-6. PubMed ID: 24568887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between the ABCG2 C421A polymorphism and Alzheimer's disease.
    Fehér Á; Juhász A; László A; Pákáski M; Kálmán J; Janka Z
    Neurosci Lett; 2013 Aug; 550():51-4. PubMed ID: 23827224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced phototoxicity evoked by inhibition of human ABC transporter ABCG2: development of in vitro high-speed screening systems.
    Tamura A; An R; Hagiya Y; Hoshijima K; Yoshida T; Mikuriya K; Ishikawa T
    Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):255-72. PubMed ID: 18363541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer resistance protein (BCRP/ABCG2).
    Staud F; Pavek P
    Int J Biochem Cell Biol; 2005 Apr; 37(4):720-5. PubMed ID: 15694832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
    Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
    Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart.
    Meissner K; Heydrich B; Jedlitschky G; Meyer Zu Schwabedissen H; Mosyagin I; Dazert P; Eckel L; Vogelgesang S; Warzok RW; Böhm M; Lehmann C; Wendt M; Cascorbi I; Kroemer HK
    J Histochem Cytochem; 2006 Feb; 54(2):215-21. PubMed ID: 16116030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biochemistry and pharmacology of the human multidrug resistance gene product, ABCG2.
    Zhang JT
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):531-41. PubMed ID: 17767037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulfasalazine disposition in a subject with 376C>T (nonsense mutation) and 421C>A variants in the ABCG2 gene.
    Gotanda K; Tokumoto T; Hirota T; Fukae M; Ieiri I
    Br J Clin Pharmacol; 2015 Nov; 80(5):1236-7. PubMed ID: 25872459
    [No Abstract]   [Full Text] [Related]  

  • 56. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
    Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
    Noguchi K; Katayama K; Mitsuhashi J; Sugimoto Y
    Adv Drug Deliv Rev; 2009 Jan; 61(1):26-33. PubMed ID: 19111841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of cells with targeted integration of gene variants of human ABC transporter for stable and regulated expression using the Flp recombinase system.
    Wakabayashi-Nakao K; Tamura A; Koshiba S; Toyoda Y; Nakagawa H; Ishikawa T
    Methods Mol Biol; 2010; 648():139-59. PubMed ID: 20700710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans.
    Kim KA; Cha YJ; Lee HM; Joo HJ; Park JY
    Clin Chim Acta; 2015 Jan; 438():7-11. PubMed ID: 25124867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABCG transporters and disease.
    Woodward OM; Köttgen A; Köttgen M
    FEBS J; 2011 Sep; 278(18):3215-25. PubMed ID: 21554546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.